Are changes in serum inflammatory markers associated with changes in apolipoprotein A1 but not B after the initiation of dialysis?
Changes in inflammatory markers were associated with changes in apo A1, but not apo B over 1 year, suggesting that reductions in high-density lipoprotein cholesterol are associated with inflammation, either of which could mediate cardiovascular risk, but not supporting a hypothesis linking increased risk of low levels of apo B containing lipoproteins to the risk associated with inflammation.
The concept of a generally increased cortical thickness in patients with atypical fractures should be reconsidered.